Prenatal Corticosteroids for Reducing Morbidity and mortality after Preterm Birth [PDF]
, 2005 Annotated and edited transcript of a Witness Seminar held on 15 June 2004. Introduction by Barbara Stocking, Oxfam. First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2005.©The Trustee of the Wellcome Trust, London, 2005.All
REYNOLDS, LA, Tansey, EM
core
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
Molecular Oncology, EarlyView.The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche +8 more
wiley +1 more source
An Index to the Biographical Notices, papers on the History of Medicine, and Reviews of Books on that subject, which have appeared in the Irish Journal of Medical Science from September, 1916 to December, 1954 [PDF]
, 1955 J. D. H. Widdess
openalex +1 more source
Molecular Oncology, EarlyView.Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner +6 more
wiley +1 more source
Propagation & brief history of Tibetan Medicine [PDF]
, 2004 この論文は国立情報学研究所の学術雑誌公開支援事業により電子化されまし
Dawa
core +1 more source
Education of History of Medicine for 80 Years: History and Current Status in Republic of Korea. [PDF]
Uisahak, 2023 Lee ST, Yeh BI.
europepmc +1 more source
Medical Library Association Handbook of Medical Library Practice with a Bibliography of the Reference Works and Histories in Medicine and the Allied Sciences [PDF]
, 1956 openalex +1 more source
Molecular Oncology, EarlyView.Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva +5 more
wiley +1 more source
The Development of Sports Medicine in Twentieth-century Britain [PDF]
, 2009 Annotated and edited transcript of a Witness Seminar held on 29 June 2007. Introduction by Dr John Lloyd Parry, Institute of Sports and Exercise Medicine. First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2009. ©The Trustee
Reynolds, LA, Tansey, EM
core